- Home
- LION vs AKRO Comparison
LION vs AKRO Comparison
Compare LION & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LION
- AKRO
- Stock Information
- Founded
- LION 1997
- AKRO 2017
- Country
- LION Canada
- AKRO United States
- Employees
- LION N/A
- AKRO N/A
- Industry
- LION Movies/Entertainment
- AKRO Biotechnology: Pharmaceutical Preparations
- Sector
- LION Consumer Discretionary
- AKRO Health Care
- Exchange
- LION Nasdaq
- AKRO Nasdaq
- Market Cap
- LION 2.0B
- AKRO 2.0B
- IPO Year
- LION N/A
- AKRO 2019
- Fundamental
- Price
- LION $7.85
- AKRO $28.08
- Analyst Decision
- LION Strong Buy
- AKRO Strong Buy
- Analyst Count
- LION 3
- AKRO 8
- Target Price
- LION $11.33
- AKRO $46.83
- AVG Volume (30 Days)
- LION 347.6K
- AKRO 594.3K
- Earning Date
- LION 02-23-2025
- AKRO 02-27-2025
- Dividend Yield
- LION N/A
- AKRO N/A
- EPS Growth
- LION N/A
- AKRO N/A
- EPS
- LION N/A
- AKRO N/A
- Revenue
- LION $2,983,500,000.00
- AKRO N/A
- Revenue This Year
- LION $5.75
- AKRO N/A
- Revenue Next Year
- LION $5.60
- AKRO N/A
- P/E Ratio
- LION N/A
- AKRO N/A
- Revenue Growth
- LION N/A
- AKRO N/A
- 52 Week Low
- LION $6.13
- AKRO $15.32
- 52 Week High
- LION $12.84
- AKRO $37.00
- Technical
- Relative Strength Index (RSI)
- LION 70.31
- AKRO 41.87
- Support Level
- LION $6.91
- AKRO $27.45
- Resistance Level
- LION $7.39
- AKRO $28.76
- Average True Range (ATR)
- LION 0.32
- AKRO 1.49
- MACD
- LION 0.07
- AKRO -0.12
- Stochastic Oscillator
- LION 97.50
- AKRO 17.98
About LION Lionsgate Studios Corp. Common Shares
Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.